Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics

被引：0
|
作者：
Abdallah Fayssoil
Olivier Nardi
David Orlikowski
Djillali Annane
机构：
[1] University of Medicine and Dentistry of New Jersey,Intensive Care Unit
[2] Raymond Poincaré Hospital,undefined
[3] AP-HP,undefined
来源：
Heart Failure Reviews | 2010年 / 15卷
关键词：
Duchenne; Dystrophin; Heart failure; ACE inhibitors; Beta-blockers; Experimental therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by the absence of dystrophin, a sarcolemmal protein which links the cytoskeleton to the extracellular matrix by interacting with a large number of proteins. Heart failure is a classic complication of this disease. The authors review the pathogenesis and therapeutics of cardiac involvement in DMD.
引用
收藏
页码：103 / 107
页数：4
相关论文
共 50 条
  • [31] Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy
    Hor, Kan N.
    Mah, May Ling
    Johnston, Pace
    Cripe, Timothy P.
    Cripe, Linda H.
    NEUROMUSCULAR DISORDERS, 2018, 28 (09) : 711 - 716
  • [32] The natural history of the cardiomyopathy of Duchenne and Becker muscular dystrophy
    Nealon, E.
    Beckman, B.
    Kertesz, N.
    Cripe, L.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S63 - S63
  • [33] DWORF Gene Therapy for Duchenne Muscular Dystrophy Cardiomyopathy
    Morales, Emily
    Yue, Yongping
    Watkins, Thais
    Han, Jin
    Pan, Xiufang
    Gibson, Aaron
    Makarewich, Catherine
    Babu, Gopal
    Duan, Dongsheng
    MOLECULAR THERAPY, 2022, 30 (04) : 493 - 493
  • [34] Imaging and Serum Biomarkers for Cardiomyopathy in Duchenne Muscular Dystrophy
    McNally, Elizabeth M.
    Chhabria, Karisma R.
    Fullenkamp, Dominic E.
    CIRCULATION-HEART FAILURE, 2023, 16 (08)
  • [35] The heart is a muscle too: the cardiomyopathy of Duchenne muscular dystrophy
    Cripe, L.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S175 - S175
  • [36] Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy
    Barber, Brent J.
    Andrews, Jennifer G.
    Lu, Zhenqiang
    West, Nancy A.
    Meaney, F. John
    Price, Elinora T.
    Gray, Ashley
    Sheehan, Daniel W.
    Pandya, Shree
    Yang, Michele
    Cunniff, Christopher
    JOURNAL OF PEDIATRICS, 2013, 163 (04): : 1080 - +
  • [37] Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
    Barp, Andrea
    Bello, Luca
    Politano, Luisa
    Melacini, Paola
    Calore, Chiara
    Polo, Angela
    Vianello, Sara
    Soraru, Gianni
    Semplicini, Claudio
    Pantic, Boris
    Taglia, Antonella
    Picillo, Ester
    Magri, Francesca
    Gorni, Ksenija
    Messina, Sonia
    Vita, Gian Luca
    Vita, Giuseppe
    Comi, Giacomo P.
    Ermani, Mario
    Calvo, Vincenzo
    Angelini, Corrado
    Hoffman, Eric P.
    Pegoraro, Elena
    PLOS ONE, 2015, 10 (10):
  • [38] Treatment with deflazacort and cardiomyopathy in Duchenne/Becker muscular dystrophy
    Politano, L
    Palladino, A
    Passamano, L
    Petretta, VR
    Comi, LI
    Nigro, G
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 581 - 582
  • [39] NATURAL COURSE OF CARDIOMYOPATHY IN DUCHENNE MUSCULAR-DYSTROPHY
    TANAKA, H
    NISHI, S
    KATANASAKO, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1979, 43 (11): : 974 - 984
  • [40] Role of Telomere Dysfunction in Duchenne Muscular Dystrophy Cardiomyopathy
    Eguchi, Asuka
    Chang, Alex C.
    Pardon, Gaspard
    Pruitt, Beth L.
    Bernstein, Daniel
    Blau, Helen M.
    CIRCULATION RESEARCH, 2019, 125
12345